The SPAC in an SEC filing said the purpose of the Extension Amendment and the Trust Amendment meeting, a time and date for which was not listed in the filing, “is to allow the company more time to complete a business combination.” Leisure said it is currently in discussions regarding a potential business combination, but the board believes that there will not be sufficient time before the Dec. 1 deadline to complete a merger. Although the last extension was approved almost unanimously by shareholders, redemptions totaled more than $176M at the time. Read more.
Related Posts
OceanTech Acquisitions I Appeals Nasdaq Delisting
In March, the original management team sold the sponsor holdings to a new team, which signed a definitive merger agreement with Israel-based Regentis Biomaterials at a $95 million valuation. However, the Nasdaq responded that the SPAC's minimum market value still had not been met within the complaince period, leading to the decision to suspend trading.
Inception Growth Acquisition Amends Proxy on $140M AgileAlgo Deal
The target is a British Virgin Islands company that, through its Singapore-based subsidiary, AgileAlgo Pte Ltd., is a maker of enterprise-grade natural language code generator for machine-learning and data management platforms.
TPG Pace Beneficial II To Shutter April 17
At the time of its April 2021 IPO, the SPAC said it was "targeting a company that combines attractive business fundamentals with, or with the potential for, strong environmental, social and governance policies."
Phoenix Biotech Adds PIPE, Adjusts CERo Deal Terms
CERo is an immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms.